Blood markers may cut biopsies in HCV (hepatitis C virus) patients
This article was originally published in Clinica
Executive Summary
Measuring a combination of five or six basic biochemical markers in blood from patients with the hepatitis C virus (HCV) could lead to a substantial reduction in the number of liver biopsy performed in those with the infection.